इसराइल - हिब्रू - Ministry of Health

teva pharmaceutical industries ltd, israel - cilazapril as monohydrate; hydrochlorothiazide - טבליה - cilazapril as monohydrate 5 mg; hydrochlorothiazide 12.5 mg - cilazapril - cilazapril - treatment of essential hypertension in patients who have been stabilized on the individual components given in the same proportions.

इसराइल - हिब्रू - Ministry of Health

glaxo smith kline (israel) ltd - diphtheria toxoid; fillamentous haemagglutinin (fha); haemophilus influenzae type b polysaccharide; inactivated polio virus (ipv) type 1; inactivated polio virus (ipv) type 2; inactivated polio virus (ipv) type 3; pertactin; pertussis toxoid (pt); tetanus toxoid - אבקה ותרחיף להכנת תרחיף להזרקה - diphtheria toxoid nlt 60 iu/ml; inactivated polio virus (ipv) type 3 64 du / 1 ml; inactivated polio virus (ipv) type 2 16 du / 1 ml; inactivated polio virus (ipv) type 1 80 du / 1 ml; pertussis toxoid (pt) 50 mcg/ml; fillamentous haemagglutinin (fha) 50 mcg/ml; pertactin 16 mcg/ml; tetanus toxoid nlt 80 iu/ml; haemophilus influenzae type b polysaccharide 20 mcg/vial - diphtheria-hemophilus influenzae b-pertussis-poliomyelitis-tetanus - diphtheria-hemophilus influenzae b-pertussis-poliomyelitis-tetanus - active immunisation in infants from the age of 2 months to 5 years against diptheria, tetanus, pertussis, poliomyelitis and haemophilus influenza type b. booster dose for children who have previously been immunised with dtp, polio and hib antigens

इसराइल - हिब्रू - Ministry of Health

glaxo smith kline (israel) ltd - diphtheria toxoid; filamentous haemagglutinin (fha); inactivated polio virus (ipv) type 1; inactivated polio virus (ipv) type 2; inactivated polio virus (ipv) type 3; pertactin (prn or 69 kda omp); pertussis toxoid vaccine; tetanus toxoid - תרחיף להזרקה - pertactin (prn or 69 kda omp) 2.5 mcg / 0.5 ml; diphtheria toxoid nlt 2 iu / 0.5 ml; tetanus toxoid nlt 20 iu / 0.5 ml; filamentous haemagglutinin (fha) 8 mcg / 0.5 ml; pertussis toxoid vaccine 8 mcg / 0.5 ml; inactivated polio virus (ipv) type 3 32 du / 0.5 ml; inactivated polio virus (ipv) type 1 40 du / 0.5 ml; inactivated polio virus (ipv) type 2 8 du / 0.5 ml - bacterial and viral vaccines, combined - for booster vaccination against diphtheria, tetanus and pertusis and poliomyelitis of individuals from the age of four years onwards. boostrix polio is not intended for primary immunisation. the administration of boostrix polio should be based on official recommendations.

इसराइल - हिब्रू - Ministry of Health

kamada ltd, israel - japanese encephalitis purified inactivated vaccine - תרחיף להזרקה - japanese encephalitis purified inactivated vaccine 6 au / 0.5 ml - encephalitis, japanese, inactivated, whole virus

इसराइल - हिब्रू - Ministry of Health

teva pharmaceutical indust.ltd - amiloride as hydrochloride 5 mg; hydrochlorothiazide 50 mg - tablets - hydrochlorothiazide and potassium-sparing agents - hypertension: kaluril is indicated in the management of hypertension either as the sole therapeutic agent or to enhance the effectiveness of other antihypertensive drugs in the more severe forms of the disease. edema: edema associated with congestive heart failure and hepatic cirrhosis.

इसराइल - हिब्रू - Ministry of Health

hirshberg brothers & co. - charcoal activated - טבליה - charcoal activated 125 mg - medicinal charcoal - medicinal charcoal - adsorption of intestinal gas as an aid in the treatment of diarrhea

इसराइल - हिब्रू - Ministry of Health

elcam medical acal - רופא - הקונפיגורציה הנוספת לסטופקוק,שסתום , מאפשרת אטימת הלואר וחוסכת את הצורך בפלג.האטימה מתבצעת על ידי רכיב סיליקוני המאפשר פתיחת הלואר על יד הכנסת מזרק או כל מחבר בעל לואר זכר. עם הוצאת המזרק או המחבר,הלואר נאטם באופן אוטומטי וללא צורך בכל פעילות ידנית של הצוות הרפואי. בכך,מעבר לנוחות בשימוש, מסייע הרכיב הסיליקוני בשמירת נקיון המוצר בעת הפרוצדורה הרפואית שכן חוסך את הצורך בסגירת ופתיחת הלואר על ידי הפלג.

इसराइल - हिब्रू - Ministry of Health

מקרוקיור - אחר - ממנת דםcurexcell™ המערכת משמשת להכנת תרחיף

इसराइल - हिब्रू - Ministry of Health

genmedix - activated charcoal 0.2 g/ml - suspension - charcoal preparations - emergency antidote in treatment of poisoning by most drugs and chemicals.

इसराइल - हिब्रू - Ministry of Health

sanofi israel ltd - diphtheria toxoid; filamentous haemagglutinin (fha); fimbrae tupes 2 + 3 (fim); inactivated polio virus (ipv) type 1; inactivated polio virus (ipv) type 2; inactivated polio virus (ipv) type 3; pertactin (prn); pertussis toxoid vaccine; tetanus toxoid - תרחיף להזרקה - fimbrae tupes 2 + 3 (fim) 5 mcg/dose; pertussis toxoid vaccine 2.5 mcg/dose; filamentous haemagglutinin (fha) 5 mcg/dose; pertactin (prn) 3 mcg/dose; diphtheria toxoid 2 lf / 1 doses; tetanus toxoid 5 lf / 1 doses; inactivated polio virus (ipv) type 1 40 du/dose; inactivated polio virus (ipv) type 2 8 du/dose; inactivated polio virus (ipv) type 3 32 du/dose - diphtheria-pertussis-poliomyelitis-tetanus - diphtheria-pertussis-poliomyelitis-tetanus - active immunization against diphtheria, tetanus, pertussis and poliomyelitis in subjects aged 3 years and over as a booster following primary immunisation . adacel polio is not indicatd for primary immunisation. adacel polio is not indicated for treating diseases caused by b. pertussis, c.diphtheriae or c. tetani or by poliomyelitis infections.